STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
dividends

BD (NYSE: BDX) has announced several key financial decisions. The Board declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025, to shareholders of record on March 10, 2025, indicating an annual dividend rate of $4.16 per share.

The company has already completed $750 million in stock repurchases in fiscal 2025. Additionally, the Board authorized the repurchase of up to 10 million additional shares of BD common stock, supplementing the remaining shares available under the 2021 authorization. The company maintains flexibility in executing these repurchases through various methods, with timing and volume determined by management based on market conditions and business factors.

Loading...
Loading translation...

Positive

  • Completed $750 million in share repurchases in FY25
  • New authorization for additional 10 million share repurchases
  • Maintaining quarterly dividend of $1.04 per share ($4.16 annually)
  • Strong capital return program indicating financial stability

Negative

  • None.

News Market Reaction 1 Alert

-0.88% News Effect

On the day this news was published, BDX declined 0.88%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRANKLIN LAKES, N.J., Jan. 28, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025 to holders of record on March 10, 2025. The indicated annual dividend rate is $4.16 per share.

The company also announced it repurchased $750 million in BD stock to date in fiscal 2025. In addition, the board has authorized the company to repurchase up to 10 million shares of BD common stock in addition to the shares that remain available under the board's previous authorization in 2021. The authorizations provide the company the ability to repurchase shares of its common stock through open market purchases, privately negotiated transactions or other methods. The actual timing, manner, number and value of any shares repurchased will be determined by management at its discretion and will depend on a number of factors, including the market price of BD's common stock, general market and economic conditions, and other business considerations.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:               




Media:                     

Investors:

Troy Kirkpatrick         

Adam Reiffe

VP, Public Relations                                                                               

Sr. Director, Investor Relations

858.617.2361                                                                       

201.847.6927

troy.kirkpatrick@bd.com                 

adam.reiffe@bd.com    

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-authorizes-10-million-additional-share-repurchases-bd-completed-750-million-repurchase-to-date-in-fy25-302362403.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What is BD's quarterly dividend amount for March 2025?

BD (BDX) declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025.

How much stock has BDX repurchased in fiscal 2025?

BD (BDX) has repurchased $750 million worth of stock to date in fiscal 2025.

What is BD's (BDX) annual dividend rate for 2025?

BD's indicated annual dividend rate is $4.16 per share.

How many additional shares did BD's board authorize for repurchase in 2025?

BD's board authorized the repurchase of up to 10 million additional shares of common stock.

When is the record date for BD's March 2025 dividend?

The record date for BD's March 2025 dividend is March 10, 2025.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

57.21B
283.69M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES